Yarmarkovich, Mark
Marshall, Quinlen F. http://orcid.org/0000-0002-4736-9716
Warrington, John M. http://orcid.org/0000-0001-6066-5491
Premaratne, Rasika
Farrel, Alvin http://orcid.org/0000-0003-1087-9840
Groff, David http://orcid.org/0000-0001-6897-2656
Li, Wei
di Marco, Moreno
Runbeck, Erin
Truong, Hau
Toor, Jugmohit S.
Tripathi, Sarvind http://orcid.org/0000-0002-6959-0577
Nguyen, Son http://orcid.org/0000-0002-0475-5158
Shen, Helena http://orcid.org/0000-0002-0500-441X
Noel, Tiffany
Church, Nicole L.
Weiner, Amber
Kendsersky, Nathan http://orcid.org/0000-0003-0132-8748
Martinez, Dan
Weisberg, Rebecca
Christie, Molly
Eisenlohr, Laurence
Bosse, Kristopher R.
Dimitrov, Dimiter S. http://orcid.org/0000-0002-2258-1024
Stevanovic, Stefan
Sgourakis, Nikolaos G.
Kiefel, Ben R.
Maris, John M. http://orcid.org/0000-0002-8088-7929
Article History
Received: 23 March 2023
Accepted: 3 October 2023
First Online: 8 November 2023
Competing interests
: J.M.M. and M.Y. have equity stake in Tantigen Bio and HuLA Therapeutics. Both companies have interest in commercializing technologies described herein. B.R.K. is an employee of and has equity interests in Myrio Therapeutics. R.P. and N.L.C. are employees of Myrio Therapeutics. J.M.M., M.Y., N.G.S. and B.R.K. are co-inventors on a patent filed regarding the PHOX2B PC-CAR.